BRUSSELS SOUTH CHARLEROIBIOPARK

THE SCIENCE-DRIVEN BIOPARK AT THE HEART OF EUROPE

1.2 B€

YEARLY BIOTECH DEAL FLOW

Biopark

2700

HIGHLY SKILLED PEOPLE

Biopark

85

LIFE SCIENCE COMPANIES

Biopark

15

CLINICAL TRIALS SITES

Biopark

6

TECHNOLOGY PLATFORMS

Biopark

3

CROSS-FACULTY RESEARCH INSTITUTES

Biopark

MORE THAN 2,000 HIGHLY SKILLED PEOPLE FROM MORE THAN 30 COUNTRIES

OUR MISSION IS TO SUPPORT COMPANY GROWTH FROM INNOVATIVE START-UPS THROUGH TO GLOBAL PLAYERS

BIOPARK SKY VIEW

Testimonials

TESTIMONIALS

GREAT PLACE TO WORK

GREAT PLACE TO INVEST

GREAT PLACE TO GROW

MARGREET BROUWERSENIOR RESEARCH ASSISTANT AT Iteos Therapeutics

Testimonials

"As a former Research Assistant at ULB and now part of iTeos’ team, a biotech company headquartered here, I am delighted to see that the BioPark has attracted so many companies and people active in the life sciences sector and that it has evolved into a dynamic working environment with excellent amenities and social activities. The park’s unique cluster reinforces collaborations, stimulates knowledge sharing and creativity."

— Margreet Brouwer, Senior Research Assistant, Iteos Therapeutics

CHRIS BUYSEMANAGING PARTNER AT Fund+

Testimonials

"The BioPark’s cluster of innovative life sciences companies and their talented, multilingual and diverse work force together with the park’s state-of-the-art facilities make it an attractive place to invest. It provides an unique ecosystem of scientific, clinical and business expertise to progress early stage research and drug development through to stages offering excellent returns on investment with remarkable impact on society.”

— Chris Buyse, Managing Partner, Fund+

DENIS BEDORET PRESIDENT AT MaSTherCell Global

Testimonials

"The BioPark’s unique focus and expertise provide the perfect environment to grow your business into a fully-fledged, global company. The hands-on support we have received from the team, along with access to the BioPark’s outstanding services, have been a great help in establishing MTC as a distinguished, international cell therapy manufacturing company.”

— Denis Bedoret, President, MaSTherCell Global

WANT TO RECEIVE OUR MONTHLY NEWSLETTER?

NEWS

April 29th 2021

Bioxodes announces the completion of the active phase of its First-in-Human study performed in healthy adult volunteers with Ir-CPI, a drug candidate for the prevention of thrombosisBioxodes, a clinical stage biotechnology company announces today the completion of the active phase of its First-in-Human (FIH) study with Ir-CPI dedicated to the prevention of thrombosis. This FIH wa...

News

April 13th 2021

Univercells signs Letters of Intent for two bioproduction projects in Senegal, strengthening Belgo-Senegalese collaborations to advance access to biologics for allUnivercells were the Institute for Health Research, Epidemiological Surveillance and Training (“IRESSEF”) and the Institut Pasteur de Dakar (“IPD”). Both IRESSEF and IPD have f...

News

EVENTS

March 29th 2021

FORMATION HELSCI - IMAGERIEIMAGE-3.9 – Introduction à la microscopie à la fluorescence – de l’utilisation du microscope aux analyses quantitatives OBJECTIFS: Obtenir les plus belles imag...

29.03.2021 / 9:00 > 5:00 PM Charleroi Gosselies Campus

Events

March 17th 2021

Essenscia jobdays chimie, plasturgie, pharma & biotech 17 – 31 mars 2021: les inscriptions pour les entreprises sont ouvertes!Votre entreprise est active dans l’innovation ou la production du secteur de la chimie, plasturgie, pharma ou biotech ? Vous recrutez ? Vous êtes intéressé·e par une a...

17.03.2021 / 9:00 > 4:00 PM Jobdays essenscia - Salon de l'emploi virtuel (plateforme ExpoPolis)

Events